Risk factors associated with rectal neuroendocrine tumors: A cross-sectional study

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 7, 2014, Pages 1406-1413

  Jung, Yoon Suk ^a   Yun, Kyung Eun ^a   Chang, Yoosoo ^a   Ryu, Seungho ^a   Park, Jung Ho ^a   Kim, Hong Joo ^a   Cho, Yong Kyun ^a   Sohn, Chong Il ^a   Jeon, Woo Kyu ^a   Kim, Byung Ik ^a   Park, Dong Il ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COLONOSCOPY; COLORIMETRY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DRINKING BEHAVIOR; FATTY LIVER; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEUROENDOCRINE TUMOR; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECTAL NEUROENDOCRINE TUMOR; RECTUM TUMOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84903996047     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0132     Document Type: Article

References (31)

1. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340: 858-68.
2. Robertson RG, Geiger WJ, Davis NB. Carcinoid tumors. Am Fam Physician 2006;74: 429-4.
3. Schnirer I, Yao JC, Ajani JA. Carcinoid-A comprehensive review. Acta Oncol 2003;42: 672-92.
4. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26: 3063-72.
5. Williams ED, Sandler M. The classification of carcinoid tum ours. Lancet 1963;1: 238-9.
6. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97: 934-9.
7. Scherubl H. Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy 2009;41: 162-5.
8. Taghavi S, Jayarajan SN, Powers BD, Davey A, Willis AI. Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis. Dis Colon Rectum 2013; 56: 952-9.
9. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder W, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9: 61-72.
10. Hassan M, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer 2008;123: 867-73.
11. Wang AY, Ahmad NA. Rectal carcinoids. Curr Opin Gastroenterol 2006;22: 529-5.
12. Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, et al. Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol 2007;14: 1735-3.
13. Matsui K, Iwase T, Kitagawa M. Small, polypoid-Appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment. Am J Gastroenterol 1993;88: 1949-3.
14. Kaminski M, Polkowski M, Regula J. Prevalence and endoscopic features of rectal neuroendocrine tumors (carcinoids) among 50148 participants of the Polish colorectal-cancer screening programme. Gut 2007;56(Suppl III): A310.
15. Shim KN, Yang SK, Myung SJ, Chang HS, Jung SA, Choe JW, et al. Atypical endoscopic features of rectal carcinoids. Endoscopy 2004;36: 313-6.
16. Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol 2010;105: 2563-9.
17. HemminkiK, LiX. Incidence trends and risk factors of carcinoid tumors: a nationwideepidemiologicstudy fromSweden.Cancer2001;92: 2204-0.
18. Jetmore AB, Ray JE, Gathright JB, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum 1992;35: 717-5.
19. Li AF, Hsu C, Tai L, Liang W, Li W, Tsay S, et al. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer 2008;112: 274-83.
20. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 1994;3: 205-7.
21. Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control 2002;13: 27-4.
22. Esposito K, Capuano A, Giugliano D. Metabolic syndrome and cancer: holistic or reductionist? Endocrine 2014;45: 362-4.
23. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-Analysis. Diabetes Care 2012;35: 2402-1.
24. Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-Analysis. Endocrine 2013;44: 634-7.
25. Jafri H, Alsheikh Ali A, Karas RH. Baseline and on-Treatment highdensity lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-Altering therapy. J Am Coll Cardiol 2010; 55: 2846-4.
26. Ulmer H, Borena W, Rapp K, Klenk J, Strasak A, Diem G, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 2009;101: 1202-6.
27. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011;60: 1094-2.
28. Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, et al. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med 2011;270: 41-9.
29. Huang KW, Leu HB, Wang YJ, Luo JC, Lin HC, Lee FY, et al. Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy. Colorectal Dis 2013; 15: 830-5.
30. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 2011;1229: 45-2.
31. Wong VW, Hui AY, Tsang SW, Chan JL, Tse AM, Chan K, et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006;4: 1154-61.